Skip to content

Medical technology company, Sky Medical, recognized with King's Award for enterprise excellence in innovation, thanks to geko device.

Medical innovation pioneer, Sky Medical Technology Ltd, has been honored with the esteemed King's Award for Enterprise in the Innovation category, thanks to their geko device.

Medical Technology firm Sky wins prestigious King's Award for pioneering innovation in the geko...
Medical Technology firm Sky wins prestigious King's Award for pioneering innovation in the geko device.

Sky Medical Technology's Geko Device Revolutionises Chronic Wound Care

Medical technology company, Sky Medical, recognized with King's Award for enterprise excellence in innovation, thanks to geko device.

In a significant breakthrough for the medical industry, Sky Medical Technology Ltd, a UK-based medical device innovator and manufacturer, has been awarded the King's Award for Enterprise in Innovation. The award was given for Sky Medical Technology's groundbreaking wound care technology, the Geko device.

The Geko device, one of only 197 organisations to receive the King's Award this year, is making waves in the healthcare sector with its innovative approach to chronic wound care. Clinicians are reporting an immediate reduction in pain associated with the use of the device, and its adoption is on the rise.

Fiona Young, Firstkind Wound Therapy Business Director, commented that the Geko device delivers real-world value clinically, operationally, and economically. The number of prescriptions for the device is increasing by over 60% quarter-over-quarter for the last 3 consecutive quarters, and it is experiencing rapid adoption across multiple NHS primary care clinics.

The pivotal randomised self-controlled trial (RCT) for the Geko device has shown a more than twofold increase in the rate of chronic wound healing. The rapid effect of the device on healing is engaging patients and keeping them on protocol, driving a transformation in chronic wound care and enabling scalable, cost-effective healthcare delivery across major markets.

The Geko device increases lower limb blood flow using its proprietary neuromuscular electrostimulation technology, accelerating healing and recovery. It addresses the unmet need in chronic wound care with a clinically validated, non-invasive therapy. With FDA clearance, NICE guidance, and integration across NHS Trusts and international health systems, the company claims the Geko device is establishing a new standard in chronic wound management.

While the search results do not specifically mention the Geko device by Sky Medical Technology, they highlight several advancements in non-invasive wound healing technologies. These include bioengineered skin substitutes, Platelet-Rich Plasma (PRP) therapy, Negative Pressure Wound Therapy (NPWT), combined oxygen therapy, and point-of-care thermography.

The Geko device, however, stands out with its unique approach. It primarily uses neuromuscular electrical stimulation to enhance blood flow, which could indirectly support wound healing by improving circulation. The device's specific role in non-invasive wound healing may require direct reference to its product documentation or clinical studies.

Despite the ongoing challenges posed by chronic wounds, which remain a critical global health challenge, costing healthcare systems billions annually, the Geko device offers a promising solution. Its rapid rate of adoption since its UK commercial launch in February 2024 and Q1 sales results that are over budget suggest a bright future for this innovative medical device.

[Note: The Geko device's specific role in non-invasive wound healing may require direct reference to its product documentation or clinical studies.]

References:

  1. Bioengineered Skin Substitutes
  2. Combining Topical Oxygen with NPWT
  3. Negative Pressure Wound Therapy (NPWT)
  4. Point-of-Care Thermography
  5. The award-winning Geko device by Sky Medical Technology is revolutionizing patient care in chronic wound care, contributing significantly to the medical-conditions sector.
  6. The device's unique approach, which utilizes medical plastics and neuromuscular electrical stimulation technology, positions it as a leader in health-and-wellness innovations within the technology realm.
  7. As the demand for cost-effective healthcare solutions in business continues to grow, the rapid adoption of the Geko device across various NHS primary care clinics and international health systems suggests a promising future for finance and medical-conditions management.
  8. With a pivotal randomized self-controlled trial demonstrating a more than twofold increase in the rate of chronic wound healing, the Geko device is not only enhancing health-and-wellness outcomes but also contributing to the scientific understanding of chronic wound care.

Read also:

    Latest